- Home
- ASTC vs PMCB Comparison
ASTC vs PMCB Comparison
Compare ASTC & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTC
- PMCB
- Stock Information
- Founded
- ASTC 1984
- PMCB 1996
- Country
- ASTC United States
- PMCB United States
- Employees
- ASTC N/A
- PMCB N/A
- Industry
- ASTC Biotechnology: Laboratory Analytical Instruments
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ASTC Industrials
- PMCB Health Care
- Exchange
- ASTC Nasdaq
- PMCB Nasdaq
- Market Cap
- ASTC 7.1M
- PMCB 6.6M
- IPO Year
- ASTC 1995
- PMCB N/A
- Fundamental
- Price
- ASTC $3.33
- PMCB $0.88
- Analyst Decision
- ASTC
- PMCB
- Analyst Count
- ASTC 0
- PMCB 0
- Target Price
- ASTC N/A
- PMCB N/A
- AVG Volume (30 Days)
- ASTC 25.7K
- PMCB 49.8K
- Earning Date
- ASTC 11-13-2025
- PMCB 12-12-2025
- Dividend Yield
- ASTC N/A
- PMCB N/A
- EPS Growth
- ASTC N/A
- PMCB N/A
- EPS
- ASTC N/A
- PMCB 0.01
- Revenue
- ASTC $1,049,000.00
- PMCB N/A
- Revenue This Year
- ASTC N/A
- PMCB N/A
- Revenue Next Year
- ASTC N/A
- PMCB N/A
- P/E Ratio
- ASTC N/A
- PMCB $139.83
- Revenue Growth
- ASTC N/A
- PMCB N/A
- 52 Week Low
- ASTC $3.07
- PMCB $0.79
- 52 Week High
- ASTC $8.15
- PMCB $1.94
- Technical
- Relative Strength Index (RSI)
- ASTC 34.24
- PMCB 38.77
- Support Level
- ASTC $3.13
- PMCB $0.79
- Resistance Level
- ASTC $4.19
- PMCB $0.93
- Average True Range (ATR)
- ASTC 0.20
- PMCB 0.05
- MACD
- ASTC -0.04
- PMCB -0.01
- Stochastic Oscillator
- ASTC 22.28
- PMCB 36.68
About ASTC Astrotech Corporation (DE)
Astrotech Corp is a science and technology development company. The firm invents, acquires, and commercializes technological innovations sourced from internal research, universities, laboratories, and research institutions. The 1st Detect develops, manufactures, and sells chemical analyzers for use in the airport security, military, and breath analysis markets. AgLAB develops a series of mass spectrometers for use in the agriculture market.
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.